Nano-based drug delivery or targeting to eradicate bacteria for infection mitigation: a review of recent advances

YC Yeh, TH Huang, SC Yang, CC Chen… - Frontiers in …, 2020 - frontiersin.org
Pathogenic bacteria infection is a major public health problem due to the high morbidity and
mortality rates, as well as the increased expenditure on patient management. Although there …

Nanocarriers based novel and effective drug delivery system

S Khizar, N Alrushaid, FA Khan, N Zine… - International Journal of …, 2023 - Elsevier
Nanotechnology has ultimately come into the domain of drug delivery. Nanosystems for
delivery of drugs are promptly emerging science utilizing different nanoparticles as carriers …

Citrate-regulated synthesis of hydrotalcite-like compounds as peroxymonosulfate activator-Investigation of oxygen vacancies and degradation pathways by combining …

L Qin, H Ye, C Lai, S Liu, X Zhou, F Qin, D Ma… - Applied Catalysis B …, 2022 - Elsevier
This work investigated the triggering mechanism of peroxymonosulfate (PMS) activated by
an oxygen vacancy (O v)-rich cobalt (Co)-based hydrotalcite-like compound (CA-LDH). CA …

Antimicrobial mechanisms and effectiveness of graphene and graphene-functionalized biomaterials. A scope review

H Mohammed, A Kumar, E Bekyarova… - … in bioengineering and …, 2020 - frontiersin.org
Bacterial infections represent nowadays the major reason of biomaterials implant failure,
however, most of the available implantable materials do not hold antimicrobial properties …

Towards improvements for penetrating the blood–brain barrier—recent progress from a material and pharmaceutical perspective

Q He, J Liu, J Liang, X Liu, W Li, Z Liu, Z Ding, D Tuo - Cells, 2018 - mdpi.com
The blood–brain barrier (BBB) is a critical biological structure that prevents damage to the
brain and maintains its bathing microenvironment. However, this barrier is also the obstacle …

[HTML][HTML] Nanoparticles-based therapeutics for the management of bacterial infections: a special emphasis on FDA approved products and clinical trials

F Aflakian, F Mirzavi, HT Aiyelabegan… - European Journal of …, 2023 - Elsevier
Microbial resistance has increased in recent decades as a result of the extensive and
indiscriminate use of antibiotics. The World Health Organization listed antimicrobial …

Functionalized graphene platforms for anticancer drug delivery

S Sattari, M Adeli, S Beyranvand… - International Journal of …, 2021 - Taylor & Francis
Two-dimensional nanomaterials are emerging as promising candidates for a wide range of
biomedical applications including tissue engineering, biosensing, pathogen incapacitation …

Metal oxide nanocarrier for targeted drug delivery towards the treatment of global infectious diseases: A review

S Saha, MR Ali, MA Khaleque, MS Bacchu… - Journal of Drug Delivery …, 2023 - Elsevier
Conventional systems for drug delivery vehicles face many limitations, thus, there have been
an extensive investigation for alternative strategies. In the last decade, nanotechnology had …

Nanotechnology in drug and gene delivery

S Hamimed, M Jabberi, A Chatti - Naunyn-schmiedeberg's Archives of …, 2022 - Springer
Over the last decade, nanotechnology has widely addressed many nanomaterials in the
biomedical area with an opportunity to achieve better-targeted delivery, effective treatment …

Nano delivery systems to the rescue of ciprofloxacin against resistant bacteria “E. coli; P. aeruginosa; Saureus; and MRSA” and their infections

JC Nwabuife, CA Omolo, T Govender - Journal of Controlled Release, 2022 - Elsevier
Ciprofloxacin (CIP) a broad-spectrum antibiotic, is used extensively for the treatment of
diverse infections and diseases of bacteria origin, and this includes infections caused by E …